Home / NKGN : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NKGN make money? Does NKGN have pricing power? What's the Earnings Whisper? Will NKGN profit more as the business scales? What is NKGN's management track record? Is NKGN's current price justified?

NKGen Biotech, Inc. Common Stock

$0 -$0.05 (-95.80%)

OTC · 09 Sep 2026 18:54 UTC

Previous Close

Day Range

$0 - $0

Year Range

$0$0.77

Market Cap

274.26K

AVG Volume

4.56K

Trailing/Forward PE

-0/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD)

NKGN Revenue (USD) by quarter
Period	Revenue (USD)
25 Q1	0
24 Q4	652K
24 Q3	0
24 Q2	0
24 Q1	0
23 Q4	0
23 Q3	0
23 Q2	0
23 Q1	0
22 Q4	0

Net Income (USD)

NKGN Net Income (USD) by quarter
Period	Net Income (USD)
25 Q1	15.35M
24 Q4	-29.41M
24 Q3	6.6M
24 Q2	-16.09M
24 Q1	-5.38M
23 Q4	-33.61M
23 Q3	-33.18M
23 Q2	-7.85M
23 Q1	-8.32M
22 Q4	-6.95M

Operating Income (USD)

NKGN Operating Income (USD) by quarter
Period	Operating Income (USD)
25 Q1	-4.67M
24 Q4	-5.1M
24 Q3	-6.79M
24 Q2	-7.46M
24 Q1	-7.62M
23 Q4	-9.43M
23 Q3	-6.9M
23 Q2	-6.61M
23 Q1	-6.8M
22 Q4	-6.26M

EBITDA (USD)

NKGN EBITDA (USD) by quarter
Period	EBITDA (USD)
25 Q1	16.24M
24 Q4	13.02M
24 Q3	7.4M
24 Q2	-15.12M
24 Q1	-3.99M
23 Q4	-32.86M
23 Q3	-32.67M
23 Q2	-7.49M
23 Q1	-7.98M
22 Q4	-5.58M

Cash Flows (USD)

NKGN Cash Flows (USD) by quarter
Period	Cash Flows (USD)
25 Q1	-2.85M
24 Q4	-6.94M
24 Q3	-3.91M
24 Q2	-6M
24 Q1	-4.03M
23 Q4	-6.96M
23 Q3	-4.57M
23 Q2	-5.55M
23 Q1	-4.93M
22 Q4	-5.47M

EPS (USD)

NKGN EPS (USD) by quarter
Period	EPS (USD)
25 Q1	-0.04
24 Q4	-0.77
24 Q3	0.15
24 Q2	-0.67
24 Q1	-0.25
23 Q4	-1.54
23 Q3	-2.48
23 Q2	-0.11
23 Q1	0.02
22 Q4	-0.14

Expenses (USD)

NKGN Expenses (USD) by quarter
Period	Expenses (USD)
25 Q1	4.72M
24 Q4	5.41M
24 Q3	6.8M
24 Q2	7.46M
24 Q1	7.62M
23 Q4	9.45M
23 Q3	6.9M
23 Q2	6.61M
23 Q1	6.81M
22 Q4	6.25M

Cash & Debt (USD)

NKGN Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
25 Q1	6K
24 Q4	0
24 Q3	8K
24 Q2	79K
24 Q1	34K
23 Q4	26K
23 Q3	8.79M
23 Q2	41.46K
23 Q1	206.8K
22 Q4	117K

Debt ratios

NKGN Debt ratios by quarter
Period	Debt ratios
25 Q1	1.77
24 Q4	0
24 Q3	-0.69
24 Q2	-0.33
24 Q1	-0.29
23 Q4	-0.25
23 Q3	-0.21
23 Q2	-0.01
23 Q1	0.01
22 Q4	-0.89

Margins

NKGN Margins by quarter
Period	Margins
24 Q4	50%
22 Q3	100%

Return on Capital

NKGN Return on Capital by quarter
Period	Return on Capital
25 Q1	-30.5%
24 Q3	-14.02%
24 Q2	23.08%
24 Q1	9.78%
23 Q4	57.26%
23 Q3	81.64%
23 Q2	-14.47%
23 Q1	-4.91%
22 Q4	-444.53%
22 Q3	-3.98%

Shares Outstanding

NKGN Shares Outstanding by quarter
Period	Shares Outstanding
25 Q1	28.83M
24 Q4	28.83M
24 Q3	29.13M
24 Q2	24.17M
24 Q1	21.94M
23 Q4	21.89M
23 Q3	13.4M
23 Q2	16.83M
23 Q1	21.45M
22 Q4	21.45M

Book Value Per Share (USD)

NKGN Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
25 Q1	-1.75
24 Q4	0
24 Q3	-1.62
24 Q2	-2.88
24 Q1	-2.51
23 Q4	-2.68
23 Q3	-3.03
23 Q2	3.22
23 Q1	7.9
22 Q4	0.07

Total Assets (USD)

NKGN Total Assets (USD) by quarter
Period	Total Assets (USD)
25 Q1	15.84M
24 Q4	24K
24 Q3	14.99M
24 Q2	15.65M
24 Q1	16.32M
23 Q4	16.48M
23 Q3	25.2M
23 Q2	63.61M
23 Q1	175.68M
22 Q4	16.33M

Employee Count

NKGN Employee Count by quarter
Period	Employee Count
2024	26
2023	63

PE Ratio

NKGN PE Ratio by quarter
Period	PE Ratio
Dec 22	21.22
Dec 22	21.18
Dec 22	21.22
Dec 22	21.24
Nov 22	21.24
Nov 22	21.15
Nov 22	21.09
Nov 22	21.09
Oct 22	20.96
Oct 22	20.92
Oct 22	20.9
Oct 22	20.9
Sep 22	20.83
Sep 22	200.11
Sep 22	199.5
Sep 22	199.5
Sep 22	198.88
Aug 22	199.09
Aug 22	199.9
Aug 22	199.9
Aug 22	200.11
Jul 22	200.11
Jul 22	199.7
Jul 22	199.7
Jul 22	199.7
Jul 22	199.29

Free Cash Flow Yield

NKGN Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-32536.8%
Sep 26	-34163.64%
Aug 26	-34163.64%
Aug 26	-13665.46%
Aug 26	-13665.46%
Aug 26	-13665.46%
Jul 26	-6832.73%
Jul 26	-1138.79%
Jul 26	-1138.79%
Jul 26	-1138.79%
Jul 26	-1138.79%
Jun 26	-1138.79%
Jun 26	-1138.79%
Jun 26	-1138.79%
Jun 26	-1138.79%
May 26	-1138.79%
May 26	-1138.79%
May 26	-1138.79%
May 26	-854.09%
May 26	-1138.79%
Apr 26	-1138.79%
Apr 26	-1138.79%
Apr 26	-1138.79%
Apr 26	-1138.79%
Mar 26	-1138.79%
Mar 26	-455.52%
Mar 26	-1138.79%
Mar 26	-341.64%
Feb 26	-1138.79%
Feb 26	-1138.79%
Feb 26	-1138.79%
Feb 26	-1138.79%
Jan 26	-1138.79%
Jan 26	-1138.79%
Jan 26	-1207.12%
Jan 26	-1207.12%
Jan 26	-1448.54%
Dec 25	-1316.86%
Dec 25	-1448.54%
Dec 25	-1957.49%
Dec 25	-1957.49%
Nov 25	-2011.86%
Nov 25	-3448.91%
Nov 25	-3448.91%
Nov 25	-3621.36%
Oct 25	-3621.36%
Oct 25	-3621.36%
Oct 25	-3621.36%
Oct 25	-36213.57%
Oct 25	-358733.48%
Sep 25	-652.24%
Sep 25	-541.48%
Sep 25	-541.48%
Sep 25	-503.49%
Aug 25	-539.45%
Aug 25	-541.48%
Aug 25	-512.48%
Aug 25	-512.48%
Aug 25	-512.48%
Jul 25	-377.61%
Jul 25	-298.94%
Jul 25	-239.08%
Jul 25	-239.16%
Jun 25	-298.7%
Jun 25	-286.99%
Jun 25	-217.41%
Jun 25	-211.02%
May 25	-254.42%
May 25	-247.57%
May 25	-205.11%
May 25	-419.57%
May 25	-564.49%
Apr 25	-529.5%
Apr 25	-562.72%
Apr 25	-623.34%
Apr 25	-398.59%
Mar 25	-439.36%
Mar 25	-462.29%
Mar 25	-422.54%
Mar 25	-355.01%
Feb 25	-134.48%
Feb 25	-125.98%
Feb 25	-113.7%
Feb 25	-167.75%
Jan 25	-146.87%
Jan 25	-138.88%
Jan 25	-162.99%
Jan 25	-146.72%
Jan 25	-104.25%
Dec 24	-125.03%
Dec 24	-139.35%
Dec 24	-178.44%
Dec 24	-203.43%
Nov 24	-222.96%
Nov 24	-254.82%
Nov 24	-337.95%
Nov 24	-331.54%
Nov 24	-333.78%
Oct 24	-223.41%
Oct 24	-223.08%

Price to Sales

NKGN Price to Sales by quarter
Period	Price to Sales
Sep 26	0.09
Sep 26	0.09
Aug 26	0.09
Aug 26	0.22
Aug 26	0.22
Aug 26	0.22
Jul 26	0.44
Jul 26	2.65
Jul 26	2.65
Jul 26	2.65
Jul 26	2.65
Jun 26	2.65
Jun 26	2.65
Jun 26	2.65
Jun 26	2.65
May 26	2.65
May 26	2.65
May 26	2.65
May 26	3.54
May 26	2.65
Apr 26	2.65
Apr 26	2.65
Apr 26	2.65
Apr 26	2.65
Mar 26	2.65
Mar 26	6.63
Mar 26	2.65
Mar 26	8.84
Feb 26	2.65
Feb 26	2.65
Feb 26	2.65
Feb 26	2.65
Jan 26	2.65
Jan 26	2.65
Jan 26	2.65
Jan 26	2.65
Jan 26	2.21
Dec 25	2.43
Dec 25	2.21
Dec 25	1.64
Dec 25	1.64
Nov 25	1.59
Nov 25	0.93
Nov 25	0.93
Nov 25	0.88
Oct 25	0.88
Oct 25	0.88
Oct 25	0.88
Oct 25	0.09
Dec 23	15367.65
Dec 23	18845
Dec 23	19069.35
Dec 23	18957.18
Nov 23	16433.29
Nov 23	15704.17
Nov 23	16377.21
Nov 23	17106.33
Oct 23	19798.47
Oct 23	16769.81
Oct 23	16825.9
Oct 23	19630.21
Sep 23	46551.65
Sep 23	68359.98
Sep 23	72578.84
Sep 23	74366.5
Sep 23	75439.09
Aug 23	73508.43
Aug 23	74795.54
Aug 23	74151.98
Aug 23	74151.98
Jul 23	74366.5
Jul 23	74438.01
Jul 23	75224.57
Jul 23	74080.48
Jun 23	73865.96
Jun 23	73651.44
Jun 23	73651.44
Jun 23	73508.43
Jun 23	73579.93
May 23	73222.4
May 23	74294.99
May 23	73007.88
May 23	72793.36
Apr 23	72793.36
Apr 23	72793.36
Apr 23	72936.37
Apr 23	72578.84
Mar 23	72435.83
Mar 23	72864.87
Mar 23	72435.83
Mar 23	72507.34
Mar 23	72364.32
Feb 23	72435.83
Feb 23	72149.81
Feb 23	72006.79
Feb 23	72006.79
Jan 23	71863.78
Jan 23	71792.27
Jan 23	71577.76
Jan 23	71863.78

EV/EBITDA

NKGN EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	1.78
Sep 26	1.78
Aug 26	1.78
Aug 26	1.78
Aug 26	1.78
Aug 26	1.78
Jul 26	1.79
Jul 26	1.85
Jul 26	1.85
Jul 26	1.85
Jul 26	1.85
Jun 26	1.85
Jun 26	1.85
Jun 26	1.85
Jun 26	1.85
May 26	1.85
May 26	1.85
May 26	1.85
May 26	1.88
May 26	1.85
Apr 26	1.85
Apr 26	1.85
Apr 26	1.85
Apr 26	1.85
Mar 26	1.85
Mar 26	1.97
Mar 26	1.85
Mar 26	2.04
Feb 26	1.85
Feb 26	1.85
Feb 26	1.85
Feb 26	1.85
Jan 26	1.85
Jan 26	1.85
Jan 26	1.32
Jan 26	1.32
Jan 26	1.1
Dec 25	1.21
Dec 25	1.1
Dec 25	0.81
Dec 25	0.81
Nov 25	0.79
Nov 25	0.46
Nov 25	0.46
Nov 25	0.44
Oct 25	0.44
Oct 25	0.44
Oct 25	0.44
Oct 25	0.04

Price to Book

NKGN Price to Book by quarter
Period	Price to Book
Dec 23	0.85
Dec 23	1.04
Dec 23	1.05
Dec 23	1.05
Nov 23	0.91
Nov 23	0.87
Nov 23	0.91
Nov 23	0.95
Oct 23	1.09
Oct 23	0.93
Oct 23	0.93
Oct 23	1.09
Sep 23	2.57
Sep 23	1.21
Sep 23	1.29
Sep 23	1.32
Sep 23	1.34
Aug 23	1.3
Aug 23	1.32
Aug 23	1.31
Aug 23	1.31
Jul 23	1.32
Jul 23	1.32
Jul 23	1.33
Jul 23	1.31
Jun 23	1.31
Jun 23	141.37
Jun 23	141.37
Jun 23	141.09
Jun 23	141.23
May 23	140.54
May 23	142.6
May 23	140.13
May 23	139.72
Apr 23	139.72
Apr 23	139.72
Apr 23	139.99
Apr 23	139.31
Mar 23	139.03
Mar 23	1.3
Mar 23	1.29
Mar 23	1.29
Mar 23	1.29
Feb 23	1.29
Feb 23	1.29
Feb 23	1.28
Feb 23	1.28
Jan 23	1.28
Jan 23	1.28
Jan 23	1.28
Jan 23	1.28
Dec 22	1.27
Dec 22	1.27
Dec 22	1.27
Dec 22	1.27
Dec 22	1.27
Nov 22	1.27
Nov 22	1.27
Nov 22	1.26
Nov 22	1.26
Oct 22	1.26
Oct 22	1.25
Oct 22	1.25
Oct 22	1.25
Sep 22	1.25
Sep 22	1.29
Sep 22	1.29
Sep 22	1.29
Sep 22	1.28
Aug 22	1.28
Aug 22	1.29
Aug 22	1.29
Aug 22	1.29
Jul 22	1.29
Jul 22	1.29
Jul 22	1.29
Jul 22	1.29
Jul 22	1.28
Jun 22	1.3
Jun 22	1.3
Jun 22	1.3
Jun 22	1.3
May 22	1.29
May 22	1.29
May 22	1.29
May 22	1.3
Apr 22	1.3
Apr 22	1.3
Apr 22	1.3
Apr 22	1.3
Apr 22	1.3
Mar 22	1.28
Mar 22	1.28
Mar 22	1.28
Mar 22	1.28
Feb 22	1.29
Feb 22	1.29
Feb 22	1.29
Feb 22	1.28
Jan 22	1.28

No video analysis for this stock yet. Request one from our team.

News: NKGN

globenewswire.com · 10 Sep 2026

NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026

SANTA ANA, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that NKGen Chairman and Chief Executive Officer Paul Y. Song, M.D., will present on the potential of troculeucel, the Company's lead investigational program, for the treatment of neurodegenerative diseases at Biologics Manufacturing Korea 2026, taking place September 17-18, 2026, in Incheon, South Korea.

globenewswire.com · 2 Jul 2026

NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel's Potential in Alzheimer's Disease and Other Neurodegenerative Conditions

SANTA ANA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that NKGen Chairman and Chief Executive Officer Paul Y. Song, M.D., will present on the Company's lead investigational program, troculeucel, at the 2026 BIOCHINA Global Forum, taking place July 9–10, 2026, in Seoul, South Korea.

globenewswire.com · 2 Jul 2026

NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions

SANTA ANA, Calif. , July 02, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ("NK") cell therapeutics, today announced that NKGen Chairman and Chief Executive Officer Paul Y.